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This article examines the comparative impact of COVID-19 in terms of
the number of cases per capita and the per capita mortality rate and analyzes the relationships between these impact estimates and three policy
measures in 20 OECD countries, controlling for the population over age
65. The policy measures involve public and private health expenditures
prior to the pandemic onset and per capita fiscal expenditures devoted to
policies designed to address the pandemic, which are identified in the International Monetary Fund’s policy tracker. The findings show no relationship between the policy measures and COVID-19 when controlling for
the population over 65 years of age.
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Introduction
Intense anxiety, uncertainty, and controversy surround the
COVID-19 pandemic, which complicate empirical analyses. The
worry stems from the exponential growth associated with the rate
of contagion and the mortality rates that were initially estimated to
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reach two million in the U.S. and ½ million in the U.K. in the absence of mitigation efforts (Ferguson et al., 2020). Although so far
the initial mortality rate estimates have overstated the deadliness of
this virus, the daily media coverage of cases, hospitalizations and
heart-wrenching accounts of people dying alone continue to fuel
public anxieties. In the United States, for example, attention-grabbing headlines frequently report the U.S. as having the “world’s
highest COVID-19 death toll,” ignoring the fact that the U.S. has a
larger population than most other wealthy countries in the world
(Ansari & Prang, 2020; Finnegan, 2020). Compared to other Organization for Economic Cooperation and Development (OECD) countries, the mortality rate per million in the U.S. was lower than U.K.,
Spain, Italy, and Belgium. Belgium’s mortality rate is twice that of
its neighbor the Netherlands (Roser et al., 2020).
But, this reflects in part the way deaths are counted in Belgium,
where about 95% of the deaths registered as COVID-19 cases in
elderly care homes have not been diagnosed with a confirmed infection (Ainger, 2020). According to the head of the viral disease
division at Belgium’s National public-health institute, “If you want
to compare our numbers with a lot of other countries, you basically
have to cut them in half” (Ainger, 2020, para. 5).
Public concerns are also elevated by the uncertainty conveyed
in data and expert opinions about the current rates of infection, future prospects, and how accurately the rates of infection and their
impact are being measured. Stretching well beyond the measurement of the Belgic mortality rate, an analysis of 36 studies found
estimates of infection fatality rates ranging from 0.00% to 1.63% in
different locations; when corrected for the types of antibodies assessed, these values ranged from 0.00% to 1.31% (Ioannidis, 2020)
—small differences in percent, which translate to huge differences
in the numbers of deaths.
Uncertainty concerning the accuracy of infection fatality rates
is amplified by alternative perspectives, which magnify and minimize what the blurry facts signify. Thus, some observers point out
that controlling for population size, the number of deaths attributed to COVID-19 in the U.S. (151,000 in July 2020), for example, was
slightly less than that caused by the 1958 Hong Kong flu pandemic
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and similar to the 1968 flu (Centers for Disease Control and Prevention [CDC], 2020a; Koops, 2020). Others could argue that with
the exponential spread of infections, the current number of deaths
in the U.S. would be much higher in the absence of protective measures taken by governments (CDC, 2020a).
Even the actual number of deaths caused by COVID-19 is questioned, due to the high rate of co-morbidity associated with these
fatalities. In the U.S., the Centers for Disease Control and Prevention reports that COVID-19 was the only cause of death mentioned
in 6% of the fatalities (CDC, 2020a). According to the CDC data:
“For deaths with conditions or causes in addition to COVID-19, on
average, there were 2.6 additional conditions or causes per death”
(CDC, 2020b). Similarly, Chow et al. (2020) found that 96% of
COVID-19 fatalities suffered from comorbidities. The prevalence of
comorbidities creates uncertainties about causality—that is, the extent to which deaths that are attributed to COVID-19 involve people dying with the disease or from the disease. The official counts of
COVID-19 deaths have been challenged on both sides of the ledger.
CDC (2020b guidelines suggest:
In cases where a definite diagnosis of COVID–19 cannot be made,
but it is suspected or likely (e.g., the circumstances are compelling
within a reasonable degree of certainty), it is acceptable to report
COVID–19 on a death certificate as “probable” or “presumed.” In
these instances, certifiers should use their best clinical judgement
in determining if a COVID–19 infection was likely. (p. 2)

The “probable or presumed” diagnosis, along with the diversity of local rules and regulations for assigning a cause of death, have
led to conflicting claims that the number of COVID-19 deaths have
been falsely inflated and underreported (Pappas, 2020). Analyzing
the data on excess deaths in the U.S., Pappas (2020) tentatively concludes that the data suggest “COVID-19 deaths are probably being undercounted rather than overcounted” (Pappas, 2020, para.
3). However, the extent of causality still remains an open question,
particularly in light of the demographics of COVID-19 fatalities.
Elderly populations in long-term care facilities account for an estimated 40 percent of all COVID-19 fatalities in the U.S. (Comas-Herrera et al., 2021). The majority of these cases involve elderly patients with co-morbidities who may already have been in the final
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weeks or months of life (Comas-Herrera et al., 2021). In Sweden,
people in elderly care services accounted for about 70 percent of
the COVID-19 deaths as of mid-May 2020 (Stern & Klein, 2020). The
COVID-19 victims in Stockholm’s nursing homes had a remaining
median life expectancy of 5 to 9 months (Stern & Klein, 2020).
Given the uncertainty surrounding what is known about the
initial impact of COVID-19 and the implications of a second wave
of infections, the appropriate policy response is swathed in controversy, nowhere more apparent than in the case of Sweden. Most of
the OECD countries responded to the pandemic by advising or requiring citizens to wear masks in public, practice social distancing,
avoid large gatherings, and closing down almost all indoor business,
which effectively shuttered their economies. Given the anxieties and
uncertainties, public policy followed the dictum of better safe than
sorry. Political leaders and public health experts justified the damage to national economies as a necessary measure to prevent massive
fatalities. Sweden’s response did not entail shutting down the economy, closing public schools for children under 16, or requiring the
use of masks or social distancing, though many Swedes voluntarily
accepted recommendations to social distance and wear masks when
appropriate. Thus, Sweden’s less restrictive policy response could be
seen as representing a counterfactual to the prevailing measures that
closed the economies of other countries.
Given the costs of heavy economic and social restrictions, many
policymakers would naturally have an interest in how Sweden’s fatality rates and economic health compare to that of the other OECD
countries which employed more invasive measures. Those supporting the more restrictive measures could point to the experiences of Denmark and Norway, Sweden’s Nordic neighbors. The New
York Times reported that by July, Sweden had suffered 12 times
more deaths per million people than Norway, seven times more
than Finland and six times more than Denmark (Goodman, 2020).
At the same time, however, the Swedish fatality rate was lower than
that in Spain, Italy, the U.K., and Belgium, as well as New York,
Massachusetts, Connecticut, and New Jersey (Book, 2020).
As for the economy, again it depends on what countries Sweden
is being compared to and on what measures of economic well-being.
The European Commission (2020) economic forecast estimated that
in 2020 on average the GDP for European countries would decline
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by 8.3%. Sweden’s decline of 5.3% was the third lowest among the
EU countries. The forecast for 2021, however, shows an average increase of 5.8% in the GDP for EU countries, with Sweden’s projected increase of 3.1%, well below the average. Overall on the two
year change in GDP, Sweden’s projected decline of -2.2% is slightly
lower than the EU average of -2.5% (European Commission, 2020).
This brief introductory discussion of anxiety, uncertainty, and controversy conveys some of the complications surrounding efforts to
empirically grasp the impact of COVID-19 and the policy responses. Bearing in mind these issues and recognizing the limits and
variability of available data, the study reported in this paper analyzes the preparation for and responses to COVID-19 in 20 OECD
countries from a fiscal perspective. This is a preliminary analysis
in light of the fact that COVID-19 remains a moving target as cases
contract and then “hotspots” erupt, as knowledge is gained about
the demographic groups most vulnerable to this virus, and as medical treatments are rapidly being produced and tested along with
preventive vaccines.

Study Design and Data
Drawing on data from the OECD social expenditure database,
World Bank population, and the International Monetary Fund’s
policy tracker, this study describes and analyzes the comparative
impact of COVID-19 in terms of the number of cases per capita and
the per capita mortality rate in 20 OECD countries. The study first
describes how the countries rank on these impact measures and
then goes on to analyze the relationships between these measures
of COVID-19’s impact and the countries’ expenditures on relevant
policies. The policy measures involve public and private health expenditures for 2017, 2018, and 2019 onset and per capita fiscal expenditures devoted to policies designed to address the pandemic,
which are identified in the International Monetary Fund’s policy
tracker. The analysis addresses the following issues:
• To what extent is there a relationship between per capita health
expenditures prior to the outbreak and COVID-19 cases and
mortality rates? This issue here involves the degree to which
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the countries’ levels of public spending on health care systems
might mitigate the spread of COVID-19 cases and the mortality
rates—and if there is any difference in mitigating effects
between the levels of total government health expenditure and
private health expenditure. The underlying assumptions here
are that in regard to the number of cases, a well-funded health
care system would have the personnel and equipment at hand
to identify and trace cases early in the outbreak, thus limiting
the number of cases and mortality per capita in comparison to
countries with lower levels of health expenditure.
•

To what extent is there a relationship between public and private health expenditures prior to the outbreak and the countries’ fiscal responses to the COVID-19 outbreak? The issue
here concerns whether countries that spend relatively more on
health care in general are likely to invest more funding in policy
responses to COVID-19 than countries with lower healthcare
expenditures.

•

To what extent is there a relationship between COVID-19 cases
and mortality rates and the fiscal expenditures in response to
the pandemic in the sample countries? The issue here concerns
the degree to which policy expenditures initiated in response to
COVID-19 were associated with the countries’ number of cases
per capita and its mortality rates.

Government and Private Health Expenditures
Data on per capita health expenditure of 20 OECD countries between 2018 and 2019 were drawn from the OECD health statistics
database which consists of government spending and compulsory
health insurance (“Government”) as well as voluntary health insurance and private funds such as households’ out-of-pocket payments, NGOs, and private corporations (“Private”), converted to
a common currency (US dollar) and adjusted to take account of
the different purchasing power of the national currencies (using
economy-wide PPPs) (OECD, 2020).
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Policy Response Spending
The data set from the International Monetary Fund (IMF)’s
policy tracker was used to measure policy spending in response
to COVID-19. The IMF identifies three categories of responses:
fiscal; monetary/macro-financial; and exchange rates/balance of
payments. The analysis of policy spending is based on the fiscal
responses, which focus on the per capita funding directly allocated
to support measures in response to the pandemic (IMF, 2020).
Cases, deaths per capita and age
Data on number of cases and deaths per capita were drawn
from Worldometers.info (Roser et al., 2020). Data on the countries’
populations aged 65 and above were taken from the World Bank
Database (World Bank, 2020).
Statistical Analyses
The statistical analyses were performed using IBM SPSS Version
24. Using the data described above, we analyzed the relationships
between government and private healthcare spending prior to the
COVID-19 pandemic and cases and mortality rates, as well as the
association between the fiscal responses by the sample countries
and COVID-19 cases and mortality rates. Descriptive statistics were
calculated to show data characteristics. Pearson product moment
correlation coefficients were computed to examine the bi-variate
correlations among the study variables. Multiple regression was
used to test the relationships of cases per capita and deaths per capita with the policy expenditure variables, controlling for the percent of the countries’ populations age 65 and over.

Results
The results are provided in the following tables. First, Table 1
describes the ranking of cases and deaths per capita in the sample
countries. Second, Table 2 presents bivariate correlations, which
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indicate the strength and direction of associations among the study
variables: total per capita health expenditures (government and
private) prior to the outbreak, fiscal responses, COVID-19 cases
and mortality rates, and the percent of the countries’ populations
age 65 and over. Finally, Tables 3 and 4 present multiple regression
analyses of (i) the relationships between the COVID-19 cases per
capita and the government health expenditure variable, controlling
for the percent of the countries’ populations age 65 and over, and
(ii) the relationship between COVID-19 mortality rates and the government health expenditure variables controlling for the percent of
the countries’ populations age 65 and over.
Country Ranking
The rank order of the sample countries on the impact measures
of COVID-19 in terms of cases and deaths per capita is shown in Table 1. The USA, Spain, Luxembourg, Sweden and Portugal had the
relatively highest cases per capita, while Australia and New Zealand were at the bottom of the ranking. In addition, Spain, the UK,
USA, Sweden and France had the highest rates of death per capita,
while Australia and New Zealand had the lowest rates.
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Table 1. Country Rank Order by COVID Cases and Deaths Per
Capita (data extracted September 13, 2020)

Correlation Analysis
Table 2 reveals a strong positive ( r = .730) and statistically significant relationship between the COVID-19 impact variables involving cases and deaths per capita, which suggests that the case
fatality ratios in the sample countries are comparable. Among the
policy expenditure variables, the findings indicate a weak positive
(r = .374) and significant relationship between the countries’ levels
of public health care spending prior to the onset of COVID-19 and
their fiscal expenditures on policies implemented in response to the
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pandemic. This may reflect a consistency in political support for
health care spending, which primed those countries with higher
per capita government health expenditures prior to COVID-19 for
a more liberal response to the pandemic than countries with less
political support for government spending on health care. There is
no significant relationship between per capita private health care
expenditures and government expenditures prior to the onset of
COVID-19 or in response to the outbreak.
Turning to the question of to what extent the policy expenditure variables mitigate the impact of COVID-19, the findings show
a moderate positive (r = .576) and statistically significant correlation between the levels of government health expenditures prior
to COVID-19 and the case per capita. The correlation here, however, is not in the expected direction based on the assumption noted
earlier, which suggested that the well-funded health care systems
would be best prepared to stem the spread of the virus. The finding
here suggests that, perhaps, the well-funded health care systems
are not so much better prepared and equipped to limit the spread
of COVID-19, but to conduct a higher level of testing for COVID-19
than health care systems with lower levels of expenditure, and thus
those systems find and report more cases per capita.
Similarly, the association between government expenditures
and rates of death per capita is not in the expected direction. The
finding here indicates a weak positive (r = .319) significant relationship between the levels of government health expenditures
pre-COVID and the rates of death per capita. This finding is more
counterintuitive than the relationship between government health
care spending and cases per capita. The levels of spending on policies in response to the pandemic had no significant relationship
to either the cases per capita or the per capita rates of death. This
suggests that the differences in levels of policy spending initiated
in response to COVID-19 had a negligible effect on the spread and
mortality rates of COVID-19.
Finally, recognizing the heightened vulnerability and mortality
rates related to those over 65 years of age, we examined the relationships between the percent of the sample countries’ populations
over 65 and the per capita cases and mortality rates. The findings
indicated moderate positive and significant correlations between
the countries’ age demographics and cases per capita (r = .68) and
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deaths per capita (r = .48). Age was also positively related (r = .670) to
government health expenditures per capita, which may reflect that
the increasing health care costs related to aging in general. Thus, the
relationships between higher government health care expenditures
and higher rates of COVID-19 cases and deaths might be attributed
mainly to the size of the age 65 and over populations in the sample
countries. If that was the case, then we would expect to see the relationship between government health expenditures and the COVID
impacts fade when controlling for populations age 65 and over. To
explore this relationship further, we conducted a regression analysis
controlling for the population demographic variable.
Table 2. Correlations COVID-19 Cases and Deaths Per Capita,
Government Health Expenditures and Percent of Populations
Age 65 and over

Multiple Regression Analyses
A preliminary screening of the data revealed that the assumptions for multiple regression analyses were met, as no issues were
found with singularity, multicollinearity, dependence of errors,
normality, linearity, or homoscedasticity of residuals (Tabachnick
& Fidell, 2001).
Table 3 shows that, when controlling for the percent of the countries’ populations over 65 years of age, the relationship between
their levels of government health expenditure and COVID-19 cases
per capita is no longer significant. The entire model itself was significant, R2 = .459, Adjusted R2 = .436, F(2,19) = 8.33, p = .003. The
percent of the population over age 65 remains significant and explains 49.5% percent of the variance in the cases per capita.
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Table 3. Regression Analysis of cases per capita and government
health expenditure Controlling For Age

As shown in Table 4, when controlling for age, the relationship
between levels of government health expenditures and COVID
mortality rates is no longer significant. The entire model itself was
significant, R2 = .234, adjusted R2= .144, F(2,19) = 2.59, p = .10. The
percent of the population over age 65 was also significant p = 0.10
Table 4. Regression Analysis of deaths per capita and government
health expenditure Controlling For Age
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Limitations and Conclusion
The interpretation of these findings must be tempered by recognition of this exploratory study’s limitations. The sample of 20
countries is relatively small and drawn from the narrow band of
advanced industrialized OECD nations. The policy response variables are operationalized in terms of public and private per capita expenditures, a metric that encompasses financial supports for
a wide-ranging assortment of practical health-related measures,
which vary among the countries. Published peer reviewed research
on the policy response to COVID-19 is limited, since policies take
time to implement and the peer-reviewed publication process often
takes six to twelve months just to bring research into print; over
a year’s time, the empirical curves of case and mortality rates are
constantly changing. The outbreak of a second wave of infections
in many countries raises additional questions about the empirical
impact of COVID-19 specified in this study. And although 10 subjects per variable (SPV) is one rule of thumb used to specify the
minimum required subjects in multiple regression analysis, various
statistical studies recommend from 2 to 200 SPV’s for an adequate
estimation of regression coefficients (Austin & Steyerberg, 2015;
Green, 1991).
With these limiting factors in mind, the findings of this study
suggest that, among the sample countries, neither the levels of government spending on health care prior to the onset of COVID-19 nor
the levels of public expenditure on policies developed in response
to the pandemic had a significant relation to the number of cases
per capita and the mortality rates experienced in these countries
by mid-September 2020. The size of the population 65 years and
older explained 49.5% of the variance in the number of COVID-19
cases per capita. These findings are suggestive of the “dry tinder”
hypothesis, based on the idea that there is a highly vulnerable population of people (over 65 with comorbidities), a large percent of
whom die each year, and that these people are particularly susceptible to contracting and dying from COVID-19 (Klein et al., 2020).
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